SelectQuote (NYSE:SLQT) 株価情報

SELECTQUOTE INC

SelectQuote

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

SelectQuote Inc

Onex (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ONEX#TSX">ONEX</a>) reported quarterly earnings of $2.05 per share. This is a 521.21 percent increase over earnings of $0.33 per share from the same period last year. The company reported $201.00 million in sales this quarter. This is a 113.83 percent increase over sales of $94.00 million the same period last year.

Earnings

News

TSX:ONEX

CORRECTION: Onex Q1 Adj. EPS $2.05 Up From $0.33 YoY, Sales $201.00M Up From $94.00M YoY

Keybanc analyst Justin Patterson maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Overweight and raises the price target from $37 to $40.

Price Target

Analyst Ratings

PINS

Keybanc Maintains Overweight on Pinterest, Raises Price Target to $40

WIIM

MNST

MNST stock has given up its prior loss. Monster Beverage shares were trading lower after the company reported mixed Q1 financial results.

Intl Tower Hill Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/THM#AMEX">THM</a>) will report on Q1 2025.

Intl Tower Hill Mines Q1 2025 GAAP EPS Nil, Revenue Nil

Keybanc analyst Justin Patterson maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Overweight and raises the price target from $67 to $80.

Keybanc Maintains Overweight on Trade Desk, Raises Price Target to $80

Earnings Misses

UPDATE: NextNav Q1 Adj. EPS $(0.15) Misses $(0.14) Estimate, Sales $1.54M Miss $1.87M Estimate

WestPark Capital analyst Casey Ryan upgrades Ouster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NASDAQ">OUST</a>) from Hold to Buy and announces $13.68 price target.

Upgrades

OUST

WestPark Capital Upgrades Ouster to Buy, Announces $13.68 Price Target

Earnings Beats

STRW

UPDATE: Strawberry Fields REIT Q1 FFO $1.38 Beats $0.32 Estimate

Kubota (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KUBTY#OTC">KUBTY</a>) reported quarterly earnings of $1.18 per share. This is a 43.54 percent decrease over earnings of $2.09 per share from the same period last year. The company reported $4.67 billion in sales this quarter. This is a 10.57 percent decrease over sales of $5.22 billion the same period last year.

KUBTY

Kubota Q1 GAAP EPS $1.18 Down From $2.09 YoY, Sales $4.67B Down From $5.22B YoY

WestPark Capital analyst Casey Ryan reiterates WM Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) with a Buy and maintains $2.61 price target.

Reiteration

MAPS

WestPark Capital Reiterates Buy on WM Tech, Maintains $2.61 Price Target

Barclays analyst Mario Lu maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Overweight and lowers the price target from $52 to $46.

MTCH

Barclays Maintains Overweight on Match Group, Lowers Price Target to $46

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/09062623/22021_203_entrecampos_roundabout_compressed-900x600-1-2.png" alt="" class="wp-image-12678" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/09062623/22021_203_entrecampos_roundabout_compressed-900x600-1-2.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/09062623/22021_203_entrecampos_roundabout_compressed-900x600-1-2-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/09062623/22021_203_entrecampos_roundabout_compressed-900x600-1-2-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
On a mission to shrink its international footprint and contain debt, the conglomerate has sold off property holdings in what was a key European base

<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>The building units in a Lisbon urban renewal project were sold to the Portuguese central bank for around 190 million euros</li>
<li>Last year Fosun International spent 11.1 billion yuan on maturing bond payments</li>
</ul>

By Lee Shih Ta
More than a decade ago,&nbsp;Fosun International&nbsp;(0656.HK) used Portugal as a springboard for an overseas expansion strategy. Since then, the sprawling conglomerate has reversed course and its now chipping away at the onetime European hub of its global ambitions.
After progressively shedding non-essential assets to shore up its finances, the company has now sealed a deal to offload some of its interests in a business, retail and residential complex to be built in the heart of Lisbon.
This latest in a spate of Fosun divestments,&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0506/2025050600079.pdf">announced</a>&nbsp;on Tuesday, covers rights over units in two planned buildings in Lisbon's Entrecampos project. The conglomerate said the assets have been sold to Banco de Portugal, the country's central bank, for a base sum of 192,000 million euros, equivalent to around $218,000 million or 1.58 billion yuan.
The Lisbon city center site is being redeveloped as part of an ambitious urban renewal project headed up by the property arm of Portuguese insurer Fidelidade, in which Fosun International holds a controlling stake.
The assets involved in the transaction are part of a complex of six buildings accounting for around 19% of the expected construction area of the entire Entrecampos project.
<h4 class="wp-block-heading">Reducing real estate risks</h4>
In 2018, Fidelidade obtained multiple parcels of land from Lisbon's city authorities for around 274 million euros, covering a development area of around 25 hectares. The investment to develop the site was projected at between 750 million and 800 million euros, with plans to build around 900 housing units including 279 for sale and the rest earmarked as affordable rentals.
The complex, scheduled for completion in the second half of 2027, is also due to include offices, shops, restaurants and green space.
The company said the disposal would reduce risk exposure to the real estate business and help it to manage uncertainties on several fronts. Identifying prestigious occupiers of signature buildings enhanced the credibility of the project, while a reduction in lettable office space would mitigate leasing risk, Fosun International said. Proceeds of the sale would be used to replenish general operating funds.
Portugal has long been a linchpin in the company's expansion strategy. In 2014, Fosun International secured a controlling stake in insurer Fidelidade for 1 billion euros, and later came into possession of Portuguese private healthcare group Luz Saúde for 860 million euros. It also became a majority shareholder in Banco Comercial Português (BCP) for 175 million euros, pursuing a three-pronged strategy of building an insurance, healthcare and banking portfolio as a beachhead for a push into international markets.
However, the company started to scale back its reach in 2022, selling non-core assets and reversing some international investments to reduce its debt burden.
In January 2024, Fosun International sold 5.6% of Portuguese commercial bank Millennium BCP for 235 million euros, while retaining a stake of more than 20%. In May last year, a stake of around 99.74% held by a Fosun subsidiary in Hauck Aufhäuser Lampe (HAL), a German private bank, was sold to ABN Amro Bank for around 670 million euros. In July, a ski resort in northern Japan, Hoshino Tomamu, was sold off to Japanese real estate investment company YCH16 for around 40.8 billion yen ($280 million).
<h4 class="wp-block-heading">Sweeping sell-off over three years</h4>
Last year alone, divestment deals amounting to around 17.5 billion yuan were signed at the group level, and 30 billion yuan at the consolidated level, according to Fosun International's annual&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0330/2025033000849.pdf">results</a>&nbsp;released at the end of March. The company divested around 75 billion yuan between 2022 and 2024. Meanwhile, it paid bond holders 11.1 billion yuan last year on matured debt instruments in onshore and offshore markets.
Total liabilities at the end of 2024 edged up 1% to 214.1 billion yuan from a year earlier and the ratio of total liabilities to capital rose from 50% at the end of 2023 to 52%. But cash reserves increased by 13.88 billion yuan to 106.34 billion yuan. The company vowed to bring its interest-bearing liabilities attributable to the group down to around 50 billion yuan in one to two years' time.
Fosun International's revenue fell 3.1% last year to 192.14 billion yuan, while industrial operating profit totaled 4.9 billion yuan. The company made a loss of 4.35 billion yuan, mainly due to a book-value impairment of 5.1 billion yuan arising from Alibaba's repurchase of shares in logistics network Cainiao at a low price. Excluding that deal, it would have achieved a profit of 750 million yuan. Thus, the numbers on paper do not do justice to its operating performance.&nbsp;
The company completed a buyout of the Fosun Tourism business last year, but a similar move to take control of&nbsp;<a>its partially owned subsidiary&nbsp;</a>Shanghai Henlius Biotech（2696.HK）was thwarted by minority shareholders. In an earnings call, Chairman Guo Guangchang painted the failed plan as a shareholder vote of confidence in the future of the biopharma firm within the Fosun group.
Guo said the company had exited asset-heavy projects and moved instead into innovative industries "with great promise and broad prospects for growth".&nbsp;Fosun Pharma&nbsp;(2196.HK）acquired another 3.9% of Henlius Biotech shares in mid-April, bringing its total holdings to 63.43%.
Currently, Fosun International is trading around a 52-week low of HK $4.15 per share, having fallen around 8.8% so far this year, leaving its price-to-earnings (P/E) ratio languishing at 4.33 times. With the divestment strategy continuing apace, and the debt situation improving, there could be some upside potential. &nbsp;

Equities

Eurozone

Opinion

Trading Ideas

Real Estate

Fosun International Sheds Real Estate Assets In Portugal

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GHRS#NASDAQ">GHRS</a>) with a Buy and maintains $40 price target.

GHRS

HC Wainwright & Co. Reiterates Buy on GH Research, Maintains $40 Price Target

Intl Cons Airlines Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ICAGY#OTC">ICAGY</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 600 percent. This is a 225 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $7.41 billion which beat the analyst consensus estimate of $6.87 billion by 7.83 percent. This is a 6.10 percent increase over sales of $6.98 billion the same period last year.

Internationalnsolidated Airlines Group Sponsored American Depository Receipt

ICAGY

Intl Cons Airlines Group Q1 Adj. EPS $0.05 Beats $(0.01) Estimate, Sales $7.41B Beat $6.87B Estimate

Needham analyst Charles Shi maintains Onto Innovation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>) with a Buy and lowers the price target from $230 to $150.

ONTO

Needham Maintains Buy on Onto Innovation, Lowers Price Target to $150

UEIC

UEIC stock has given up its prior loss. Universal Electronics shares were trading lower following Q1 financial results.

B of A Securities analyst Jason Kupferberg maintains Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Buy and raises the price target from $76 to $80.

AFRM

B of A Securities Maintains Buy on Affirm Holdings, Raises Price Target to $80

Barclays analyst Tom O'Malley maintains MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) with a Overweight and raises the price target from $125 to $150.

MTSI

Barclays Maintains Overweight on MACOM Technology Solns, Raises Price Target to $150

HC Wainwright &amp; Co. analyst Andrew Fein maintains PepGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) with a Buy and lowers the price target from $16 to $14.

PEPG

HC Wainwright & Co. Maintains Buy on PepGen, Lowers Price Target to $14

<ul>
<li>GOOGL</li>
<li>TSLA</li>
<li>GLD</li>
<li>NVDA</li>
<li>BULL</li>
<li>PLTR</li>
<li>GOOG</li>
<li>MSTR</li>
<li>WOLF</li>
<li>AAPL</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

BULL

GOOG

GOOGL

MSTR

NVDA

PLTR

TSLA

WOLF

Top 10 Trending Stocks On WallStreetBets As Of May 9, 2025 (Via Swaggy Stocks)

Penny Stocks

Small Cap

Press Releases

Securities Fraud Investigation Into SelectQuote, Inc. (SLQT) Announced – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Legal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SelectQuote, Inc. - SLQT

SELECTQUOTE ALERT: Bragar Eagel & Squire, P.C. is Investigating SelectQuote, Inc. on Behalf of SelectQuote Stockholders and Encourages Investors to Contact the Firm

INVESTOR ALERT: Investigation of SelectQuote, Inc. (SLQT) Announced by Holzer & Holzer, LLC

Kirby McInerney LLP Announces Investigation of Claims Against SelectQuote, Inc. (SLQT) on Behalf of Investors

SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations – Hagens Berman

SLQT Investors Have Opportunity to Join SelectQuote, Inc. Fraud Investigation with the Schall Law Firm

SelectQuote Responds to Allegations in Department of Justice Complaint

SelectQuote (SLQT) Faces Investor Scrutiny After DOJ Alleges False Claims Act Violations - Hagens Berman

SLQT

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management

AIFU

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan Cos

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

SelectQuote

ニュース

パートナーシップ

ベンジンガ・グローバル